Cera Flava Alleviates Atopic Dermatitis by Activating Skin Barrier Function via Immune Regulation.

Area of Science:

• Dermatology
• Immunology
• Natural Products Research

Background:

• Cera Flava (CF) is a natural bee product with known dermatological benefits like wound healing and UV protection.
• The efficacy of CF in treating atopic dermatitis (AD)-like skin lesions remains unexplored.

Purpose of the Study:

• To investigate the effects of CF on AD-like skin lesions using a mouse model.
• To evaluate CF's impact at both molecular and phenotypic levels.

Main Methods:

• Atopic dermatitis-like lesions were induced in NC/Nga mice via topical house dust mite (HDM) sensitization and challenge.
• Mice were treated with topical CF for 6 weeks, with assessments including dermatitis severity, scratching frequency, skin moisture, and immunological markers.
• Molecular analyses included measuring immunoglobulin E, histamine, thymic stromal lymphopoietin, epidermal thickness, mast cell counts, skin barrier proteins, and inflammatory factor mRNA levels via the TLR2/MyD88/TRAF6/ERK pathway.

Main Results:

• Topical CF application significantly alleviated HDM-induced AD-like phenotypes, reducing dermatitis scores, scratching, and improving skin moisture.
• CF treatment decreased levels of immunoglobulin E, histamine, and thymic stromal lymphopoietin.
• Histopathology revealed reduced epidermal thickening and mast cell infiltration, alongside normalized expression of skin barrier proteins.
• CF downregulated mRNA expression of key inflammatory factors (IL-1β, IL-4, IL-13, IL-8, TARC, MDC, RANTES) through the TLR2 signaling pathway.

Conclusions:

• Cera Flava (CF) demonstrates significant therapeutic potential for atopic dermatitis by enhancing skin barrier function and modulating immune responses.
• CF alleviates AD symptoms and may serve as a viable natural alternative to conventional topical steroid treatments.